
Join a MASH/NASH (Fatty Liver) Research Study
Now enrolling people diagnosed with NASH/MASH (Fatty Liver) to evaluate new potential investigational treatment options.
Benefits of Joining a Clinical Trial
- Many studies include compensation for time and travel
- Study related medication and care provided at no cost
- Health insurance is not required.

A clinical trial is a carefully designed research study involving human volunteers to investigate the safety and effectiveness of a new drug or treatment. Clinical trials are essential for evaluating the benefits and risks of medical interventions, ultimately informing healthcare decisions and regulatory approvals.
As a clinical trial or observational study participant, your responsibilities and what you will be required to do can vary depending on the study, its objectives, and the phase of the trial.
Some common activities and responsibilities you may encounter as a participant include: diagnostic tests, treatments, procedures, doctor visits, dietary changes, exercise and/or other lifestyle changes. Observational studies often involve minimal effort, such as completing questionnaires, sharing test results, maintaining a diet or exercise log.
Joining a clinical trial can provide access to cutting-edge treatments, close medical monitoring, and an opportunity to contribute to medical knowledge. Participants may experience improved health outcomes and specialized care while potentially receiving compensation for volunteering.
Clinical trials are designed with a strong emphasis on the safety of participants, and multiple safeguards are in place to minimize risks, including careful study design, oversight by institutional review boards and routine monitoring of study data by independent experts. Researchers must inform participants of the risks, benefits and/or side effects they discover.
Yes, you can drop out of a clinical trial study at any time, and you have the right to do so without facing any penalties or consequences. This is often referred to as "withdrawal of consent."
Voluntary participation is a fundamental principle of clinical research. You are not obligated to continue in a trial if you no longer wish to do so.
Determining your eligibility to participate in a clinical trial involves a thorough evaluation of specific eligibility criteria set forth by the study's researchers and sponsors. The criteria help define the patient population being studied and are designed to protect the safety of participants in the trial.
Providing accurate information about your medical history and health status is crucial for your safety and the integrity of the research. If you are not eligible for one trial, you may still be eligible for other trials in the future, so it's worth exploring your options if you are interested in participating in clinical research.
Yes, we do! Have a friend or family member who may also want to participate in one of our studies?
For qualifying studies, we offer a $25 gift card for each friend or family member that you refer. Restrictions apply. Please ask about our referral program during your screening visit.
WHAT IS THE STUDY ABOUT?
We are currently seeking patients with fatty liver for two separate research studies focused on advancing treatments for Metabolic Dysfunction-Associated Steatohepatitis (MASH), also known as Nonalcoholic Steatohepatitis (NASH).
Study 1: A Pegozafermin Study
This study is looking at an investigational drug called pegozafermin to see how well it works for people with MASH and liver scarring.
Study 2: A Gene Silencing Study
This study is testing a new type of treatment that uses gene silencing to target MASH. This research is focused on people who have specific genetic risk factors for the disease.
By participating, you could help advance the development of new and effective treatment options for MASH.
WHO CAN JOIN THE STUDY?
To qualify, you must meet the following conditions:
✅18 to 85 years old
✅Diagnosed with Metabolic Dysfunction-Associated Steatohepatitis (MASH), also known as Non-Alcoholic Steatohepatitis (NASH).
✅No other liver disorders besides NASH/MASH
✅Not diagnosed with liver cirrhosis
✅Have not had a liver transplant
*Additional criteria may apply.